1.35000 USD
0.05
3.57%
Last update Dec 17, 3:59 PM EST
Market closed
Day range
1.34000
1.41000
Previous close
1.40000
Open
1.41000
Access this stock data via API
Subscribe
Telomir Pharmaceuticals Inc.
1.35
0.05
3.57%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 759.5K 42.8K 337.0K 269.1K
Selling general and admin 387.0K 5.0M 1.9M 2.6M
Other operating expenses 0
Operating income -1.1M -5.1M -2.2M -2.9M
Non operating interest income
Income 44.2K 1.4K 7.1K
Expense 0 1.3K -1
Other income expense
Pretax income -1.1M -5.1M -2.2M -2.9M
Tax provision
Net income -1.1M -5.1M -2.2M -2.9M
Basic EPS 0.0 -0.2 -0.1
Diluted EPS 0.0 -0.2 -0.1
Basic average shares 32.4M 30.0M 29.8M
Diluted average shares 32.4M 30.0M 29.8M
EBITDA -1.1M -5.1M -2.2M -2.9M
Net income from continuing op. -1.1M -5.1M -2.2M -2.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 9 minutes

03:50
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).